CN1563421A - Polymorphism detection chip for gene of enzyme relevant to ethanol metabolism, preparation method of usage - Google Patents
Polymorphism detection chip for gene of enzyme relevant to ethanol metabolism, preparation method of usage Download PDFInfo
- Publication number
- CN1563421A CN1563421A CN 200410017946 CN200410017946A CN1563421A CN 1563421 A CN1563421 A CN 1563421A CN 200410017946 CN200410017946 CN 200410017946 CN 200410017946 A CN200410017946 A CN 200410017946A CN 1563421 A CN1563421 A CN 1563421A
- Authority
- CN
- China
- Prior art keywords
- aag
- gta
- gene
- ttg
- adh2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 21
- 108090000790 Enzymes Proteins 0.000 title claims description 44
- 102000004190 Enzymes Human genes 0.000 title claims description 25
- 238000001514 detection method Methods 0.000 title claims description 8
- 230000004149 ethanol metabolism Effects 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 52
- 101710193111 All-trans-retinol dehydrogenase [NAD(+)] ADH4 Proteins 0.000 claims abstract description 32
- 102100034042 Alcohol dehydrogenase 1C Human genes 0.000 claims abstract description 31
- 239000000523 sample Substances 0.000 claims abstract description 28
- 101000796894 Coturnix japonica Alcohol dehydrogenase 1 Proteins 0.000 claims abstract description 21
- 101000780463 Homo sapiens Alcohol dehydrogenase 1C Proteins 0.000 claims abstract description 21
- 238000012360 testing method Methods 0.000 claims abstract description 21
- 102000009645 Mitochondrial Aldehyde Dehydrogenase Human genes 0.000 claims abstract description 20
- 108010009513 Mitochondrial Aldehyde Dehydrogenase Proteins 0.000 claims abstract description 20
- SNBCLPGEMZEWLU-QXFUBDJGSA-N 2-chloro-n-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CNC(=O)CCl)[C@@H](O)C1 SNBCLPGEMZEWLU-QXFUBDJGSA-N 0.000 claims abstract description 18
- 108700028369 Alleles Proteins 0.000 claims description 29
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 29
- 102100034044 All-trans-retinol dehydrogenase [NAD(+)] ADH1B Human genes 0.000 claims description 23
- 230000004060 metabolic process Effects 0.000 claims description 21
- 208000022309 Alcoholic Liver disease Diseases 0.000 claims description 14
- 101150016330 ADH3 gene Proteins 0.000 claims description 12
- 101150038502 ALDH2 gene Proteins 0.000 claims description 12
- 101150078509 ADH2 gene Proteins 0.000 claims description 11
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims description 10
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 10
- 230000015572 biosynthetic process Effects 0.000 claims description 10
- 239000002751 oligonucleotide probe Substances 0.000 claims description 10
- 238000003786 synthesis reaction Methods 0.000 claims description 10
- 238000005406 washing Methods 0.000 claims description 10
- 108091034117 Oligonucleotide Proteins 0.000 claims description 8
- 101100441878 Caenorhabditis elegans cyn-3 gene Proteins 0.000 claims description 7
- 101100464856 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cyp-3 gene Proteins 0.000 claims description 7
- 230000011664 signaling Effects 0.000 claims description 7
- 229960000583 acetic acid Drugs 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 230000002068 genetic effect Effects 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 claims description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical class O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 5
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 5
- 239000000908 ammonium hydroxide Substances 0.000 claims description 5
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 claims description 5
- 238000010511 deprotection reaction Methods 0.000 claims description 5
- 238000013461 design Methods 0.000 claims description 5
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 claims description 5
- 230000014509 gene expression Effects 0.000 claims description 5
- 239000012362 glacial acetic acid Substances 0.000 claims description 5
- 239000006210 lotion Substances 0.000 claims description 5
- 238000012805 post-processing Methods 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 4
- 239000007850 fluorescent dye Substances 0.000 claims description 3
- 230000003321 amplification Effects 0.000 claims description 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 2
- 230000002503 metabolic effect Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 101001091385 Homo sapiens Kallikrein-6 Proteins 0.000 abstract 2
- 102100034866 Kallikrein-6 Human genes 0.000 abstract 2
- 230000002596 correlated effect Effects 0.000 abstract 2
- 230000004907 flux Effects 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
- 235000019441 ethanol Nutrition 0.000 description 20
- 206010067125 Liver injury Diseases 0.000 description 5
- 231100000234 hepatic damage Toxicity 0.000 description 5
- 230000008818 liver damage Effects 0.000 description 5
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 4
- 108010044467 Isoenzymes Proteins 0.000 description 4
- 239000005357 flat glass Substances 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 101150028074 2 gene Proteins 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- 208000007848 Alcoholism Diseases 0.000 description 2
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 206010019799 Hepatitis viral Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- FQVLRGLGWNWPSS-BXBUPLCLSA-N (4r,7s,10s,13s,16r)-16-acetamido-13-(1h-imidazol-5-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide Chemical compound N1C(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CC1=CN=CN1 FQVLRGLGWNWPSS-BXBUPLCLSA-N 0.000 description 1
- 101150084750 1 gene Proteins 0.000 description 1
- 102100034035 Alcohol dehydrogenase 1A Human genes 0.000 description 1
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 1
- 208000008964 Chemical and Drug Induced Liver Injury Diseases 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 206010072268 Drug-induced liver injury Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 101000892220 Geobacillus thermodenitrificans (strain NG80-2) Long-chain-alcohol dehydrogenase 1 Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 101000780443 Homo sapiens Alcohol dehydrogenase 1A Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010001584 alcohol abuse Diseases 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 208000025746 alcohol use disease Diseases 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000022602 disease susceptibility Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 231100000594 drug induced liver disease Toxicity 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 208000021245 head disease Diseases 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000013188 needle biopsy Methods 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 239000003620 semiochemical Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000003201 single nucleotide polymorphism genotyping Methods 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
This invention discloses as alcohol metabolic zyme correlated gene pleiomorphy test chip and its preparation method and usage, designing the following probes on vectors: ADH3: 5'-AAG GTA AAA CAT TTG TTAT5'-AAG GTA AAA AAT TTG TTAT 5'-AAG GTA AAA AAT TTG TTAT5'-AAG CAT AAA GAT TTG TTATA DH2 (allelic gene 1 and allelic gene 2): 5'-AAT CTG TCG CAC AGA TG 5'-AAG GTA AAA CAT TTG TTAT5'-AAT CTG TCC CAC AGA TG5'-AAT CTG TCT CAC AGA TGA DH2(allelic gene 1 and allelic gene 3): 5'-GCA GTA TCT GTA CCG TC CCG TC5'-GCA GTA TCG CTA CCG TC ALDH2:5'-CAT ACA CTG AAG TGA AA5'-CAT ACA CTA AAG TGA AA5'-CAT ACA CTT AAG TGA AA 5'-CAT ACA CTC AAG TGAAA. The advantage is that it realizes quick, simple and high flux test to alcohol metabolic zyme correlated gene ADH2, ADH3 and ALDH2 pleiomorphy.
Description
The present invention relates to a kind of alcohol metabolism relative enzyme gene polymorphic test chips and its preparation method and application for technical field.
Background technique
Alcohol abuse and alcohol dependence have become the more worth people of the public health problem got worse in the world today, especially adolescents alcohol and pay attention to.The alcoholic liver disease past is more rare in China, therefore it is also few for studying it, but the disease incidence of alcoholic liver disease obviously increases in recent years, it has also become is only second to the second largest hepatopathy of virus hepatitis.Alcohol has an apparent toxic effect to liver, and 80% or more has a degree of fatty liver in heavy drinking essence person, and 10%-35% can develop into alcoholic hepatitis, and 10%-20% would develop into cirrhosis.
Metabolic conversion is acetaldehyde and acetic acid to alcohol (ethyl alcohol) in vivo, and predominantly alcohol dehydrogenase (alcoholdehydrogenase, ADH) and acetaldehyde dehydrogenase (aldehyde dehydrogenase, ALDH) acts on.The isodynamic enzyme ADH1 (α) that ADH has 3 kinds of different genes to encode, ADH2 (β), ADH3 (γ), there are certain polymorphisms by ADH2 and ADH3 in base, there are three allele sites by ADH2, ADH2*1, ADH2*2 and ADH2*3, it is separately encoded β 1, 3 three subunits of β 2 and β, the polymorphism of ADH2 allele is the single base replacement due to 47 (G ψ A) and 369 (C ψ T) codons:, the isoenzymes of β 1 has low Km (0.049mmol/L) and low maximal clearance (Vmax) (0.23U/min) to alcohol, the isoenzymes of β 2. compares with low Km (0.94mmol/L) maximal clearance (8.6U/min), isoenzymes β 3 With to the high Km of alcohol (36mmol/L) and high Vmax (7.9U/min).The activity of ADH3*1 expression product is 2 times of ADH3*2.The allele that ALDH2 gene encodes active and inactive subunit is named as ALDH2*1 and ALDH2*2 respectively, the difference of these isoenzymes is that the base of 487 codons exchanges (G ψ A), generates the exchange of lysine (inactive subunit) and glutamic acid (active subunit).The polymorphism of Alcohol-metabolizing enzymes related gene plays an important role in alcoholic liver disease and other metabolism and the morbidity of drug-induced liver disease.
Doing genetic analysis for SNPs is to refer in particular to a large amount of existing single nucleotide variations in detection human genome, this is related [1] with disease susceptibility and poisonous substance neurological susceptibility.SNPs is not only the label of human race and individual difference, is also the label for determining different crowd race and individual difference, can become and find disease related gene, carry out the basis of medical diagnosis on disease, prevention and drug screening.Conventional method for SNPs detection has allele specific oligonucleotide (ASO) hybridization, restriction enzyme enzyme process (RFLP), site-specific primer PCR (PCR-SSP) and direct Sequencing etc..The development of biochip technology provides possibility [2] for the detection method of new SNPs.Oligonucleotide microarray is a kind of technique of gene detection that newly-developed gets up, a large amount of oligonucleotide probe can be regularly arranged on a slide by it, these probes can be combined with the complementary series of the extension increasing sequence of the sample DNA of signal display mass signatures, by being detected to semiochemicals, software processing analysis is carried out to results of hybridization, to obtain the intensity and its distribution pattern figure of hybridization signal.
Bibliography:
[1] Khner M K, Beerli P, Yamato J, et al.Usefulness of single nucleatide polymorphismdata for estimating population parameters.Genetics, 2000,156:439-447
[2] Hirschlhorn J N, Sklar P, Lindblad-Toh K, et al.SBE-TAGS:an array-based methodfor efficient single-nucleotide polymorphism genotyping.Proc Natl Acad SciUSA, 2000,97:12164-12169
[3] Picoult-Newberg L, Idker TE, Pohl M G, et al.Mining SNPs from ESTdatabases.Genome Res, 1999,9:167-174.
[4] Yu Chaohui Chen Lihua, the preparation and application China digestion magazine 2003,23 (11) of the alcohol metabolizing enzyme oligonucleotide genetic chip such as Chen Weixing；695-6
Summary of the invention
The object of the present invention is to provide a kind of alcohol metabolism relative enzyme gene polymorphic test chips and its preparation method and application.
Alcohol metabolism relative enzyme gene polymorphic test chip: following probe is equipped on carrier:
ADH3:5 '-AAG GTA AAA CAT TTG TTAT
5’-AAG GTA AAA TAT TTG TTAT
5’-AAG GTA AAA AAT TTG TTAT
5’-AAG GTA AAA GAT TTG TTAT
ADH2 (allele 1 and allele 2): 5 '-AAT CTG TCG CAC AGA TG
5’-AAG GTA AAA CAT TTG TTAT
5’-AAT CTG TCC CAC AGA TG
5’-AAT CTG TCT CAC AGA TG
ADH2 (allele 1 and allele 3): 5 '-GCA GTA TCT GTA CCG TC
5’-GCA GTA TCC GTA CCG TC
5’-GCA GTA TCA GTA CCG TC
5’-GCA GTA TCG GTA CCG TC
ALDH2:5 '-CAT ACA CTG AAG TGA AA
5’-CAT ACA CTA AAG TGA AA
5’-CAT ACA CTT AAG TGA AA
5’-CAT ACA CTC AAG TGA AA
Alcohol metabolism relative enzyme gene polymorphic test chip preparation method step are as follows:
1) processing of chip carrier: wave carrier piece chromic acid lotion soaked overnight, washing, in 24~26% ammonium hydroxide overnight, washing, sheet glass immerses in 95% ethanol solution of aminopropyl trimethoxysilane, adjusts PH to 4~4.5, the cleaning of 95% EtOH Sonicate with glacial acetic acid, 150~160 DEG C dry 3~5 hours, and 9~11% glutaraldehydes are processed into aldehyde radical；
2) synthesis of primer and probe: a set of probe (such as table 1) is devised for Alcohol-metabolizing enzymes related gene ADH2, ADH3 and ALDH2 gene; 4 pairs of primers (such as table 2) have been synthesized for the design of Alcohol-metabolizing enzymes related gene ADH2, ADH3 and ALDH2 gene; respectively there is a Cyp-3 signaling molecule label in each pair of primer; with 75~85 DEG C of concentrated ammonia liquor deprotections after synthesis; cutting 14~17 hours; OPC column purification; it is ultraviolet it is quantitative after be dried in vacuo concentration, -20~-80 DEG C save backup；
3) genetic chip preparation and post-processing: oligonucleotide probe is dissolved in 3 × SSC solution with 15 μM of concentration, and oligonucleotides is sprayed on the slide of aldehyde radical with PixySys5500 chip preparing instrument, and point spacing is 0.5mm.After point sample, left at room temperature over night.
Alcohol metabolism relative enzyme gene polymorphic test chip is used for the polymorphic detection and parting of patients with alcoholic liver disease Alcohol-metabolizing enzymes related gene ADH2, ADH3 and ALDH2.
The present invention is by the probe spotting Jing Guo selection on slide, hybridized respectively with the DNA fragmentation of Alcohol-metabolizing enzymes related gene ADH2, ADH3 and ALDH2 through PCR amplification, disposably obtain the polymorphic situation in each site, quick, simple and direct, high-throughput detection and parting are carried out to Alcohol-metabolizing enzymes related gene polymorphism to realize, there is important social and economic benefit.
Specific embodiment
Immobilised probe is oligonucleotide probe on slide of the present invention, its sequence is designed according to the gene expression characteristics of Alcohol-metabolizing enzymes related gene ADH2, ADH3 and ALDH2, plays length range in 15-20 base, generally 18 bases, its Tm value is almost the same, at 40~43 DEG C.
Described primer is designed according to the gene expression characteristics of Alcohol-metabolizing enzymes related gene ADH2, ADH3 and ALDH2, and primer sequence length is respectively used to the amplification of said gene between 20-24 base.
Signaling molecule label is the primer expanded for the gene order of Alcohol-metabolizing enzymes related gene ADH2, ADH3 and ALDH2.Signaling molecule label is fluorescent molecule.
Table 1: the probe of alcohol metabolism relative enzyme gene polymorphic test chip
| gene | probe |
| ADH3 | 5’-AAG GTA AAA CAT TTG TTAT |
| 5’-AAG GTA AAA TAT TTG TTAT | |
| 5’-AAG GTA AAA AAT TTG TTAT | |
| 5’-AAG GTA AAA GAT TTG TTAT | |
| ADH2 (allele 1 and allele 2) | 5’-AAT CTG TCG CAC AGA TG |
| 5’-AAT CTG TCA CAC AGA TG | |
| 5’-AAT CTG TCC CAC AGA TG | |
| 5’-AAT CTG TCT CAC AGA TG | |
| ADH2 (allele 1 and allele 3) | 5’-GCA GTA TCT GTA CCG TC |
| 5’-GCA GTA TCC GTA CCG TC | |
| 5’-GCA GTA TCA GTA CCG TC | |
| 5’-GCA GTA TCG GTA CCG TC | |
| ALDH2 | 5’-CAT ACA CTG AAG TGA AA |
| 5’-CAT ACA CTA AAG TGA AA | |
| 5’-CAT ACA CTT AAG TGA AA | |
| 5’-CAT ACA CTC AAG TGA AA |
Table 2: the primer of alcohol metabolism relative enzyme gene polymorphic test chip
| Gene | Cyp-3 fluorescent dye primer | Primer |
| ADH3 | 5’-CTT TAA GAG TAA AGA ATC TGT CC-3’ | 5’-ACC TCT TTC CAG AGC GAAGCAG-3’ |
| ADH2 (allele 1 and allele 2) | 5’-GAA GGG GGG TCA CCA GGT TGC-3’ | 5’-AAT CTT TTC TGA ATCTGA ACAG-3’ |
| ADH2 (allele 1 and allele 3) | 5’-TTG ATA ACA TCT CTG AAG AGC TGA-3’ | 5’-TGG ACT CTC ACA ACA AGCATGT-3’ |
| ALDH2 | 5’-CAG GTC CCA CAC TCA CAG TTT-3’ | 5’-CAC CCT TTG GTG GCT ACAAG-3’ |
Embodiment 1: the preparation of nucleotide gene chip:
1) processing of chip carrier: wave carrier piece chromic acid lotion soaked overnight is washed, in 25% ammonium hydroxide overnight, washing.Sheet glass immerses in 95% ethanol solution of aminopropyl trimethoxysilane, adjusts PH to 4.5 with glacial acetic acid, the cleaning of 95% EtOH Sonicate, 160 DEG C dry 4 hours, and 5% glutaraldehyde is processed into aldehyde radical.
2) synthesis of primer and probe: the present invention devises a set of probe (being shown in Table 1) for Alcohol-metabolizing enzymes related gene ADH2, ADH3 and ALDH2 gene.4 pairs of primers (being shown in Table 2) have been synthesized for the design of Alcohol-metabolizing enzymes related gene ADH2, ADH3 and ALDH2 gene.Respectively there is a Cyp-3 fluorescent marker in each pair of primer.With 80 DEG C of concentrated ammonia liquor deprotections after synthesis, cut 15 hours, OPC column purification.It is ultraviolet it is quantitative after be dried in vacuo concentration, -20 DEG C save backup.
3) genetic chip preparation and post-processing: oligonucleotide probe is dissolved in 3 × SSC solution with 15 μM of concentration, and oligonucleotides is sprayed on the slide of aldehyde radical with PixySys5500 chip preparing instrument, and point spacing is 0.5mm.After point sample, left at room temperature over night.
Embodiment 2: the preparation of nucleotide gene chip:
1) processing of chip carrier: wave carrier piece chromic acid lotion soaked overnight, washing, in 24% ammonium hydroxide overnight, washing, sheet glass immerses in 95% ethanol solution of aminopropyl trimethoxysilane, adjusts PH to 4, the cleaning of 95% EtOH Sonicate with glacial acetic acid, 150 DEG C dry 3 hours, and 9% glutaraldehyde is processed into aldehyde radical；
2) synthesis of primer and probe: a set of probe is devised for Alcohol-metabolizing enzymes related gene ADH2, ADH3 and ALDH2 gene; 4 pairs of primers have been synthesized for the design of Alcohol-metabolizing enzymes related gene ADH2, ADH3 and ALDH2 gene; respectively there is a Cyp-3 signaling molecule label in each pair of primer; with 75 DEG C of concentrated ammonia liquor deprotections after synthesis; cutting 13 hours; OPC column purification, it is ultraviolet it is quantitative after be dried in vacuo concentration, -20 DEG C save backup；
3) genetic chip preparation and post-processing: oligonucleotide probe is dissolved in 3 × SSC solution with 15 μM of concentration, and oligonucleotides is sprayed on the slide of aldehyde radical with PixySys5500 chip preparing instrument, and point spacing is 0.5mm.After point sample, left at room temperature over night.
The preparation of 3 nucleotide gene chip of embodiment:
1) processing of chip carrier: wave carrier piece chromic acid lotion soaked overnight, washing, in 26% ammonium hydroxide overnight, washing, sheet glass immerses in 95% ethanol solution of aminopropyl trimethoxysilane, adjusts PH to 4.5, the cleaning of 95% EtOH Sonicate with glacial acetic acid, 160 DEG C dry 5 hours, and 11% glutaraldehyde is processed into aldehyde radical；
2) synthesis of primer and probe: a set of probe is devised for Alcohol-metabolizing enzymes related gene ADH2, ADH3 and ALDH2 gene; 4 pairs of primers have been synthesized for the design of Alcohol-metabolizing enzymes related gene ADH2, ADH3 and ALDH2 gene; respectively there is a Cyp-3 signaling molecule label in each pair of primer; with 85 DEG C of concentrated ammonia liquor deprotections after synthesis; cutting 17 hours; OPC column purification, it is ultraviolet it is quantitative after be dried in vacuo concentration, one 80 DEG C save backup；
3) genetic chip preparation and post-processing: oligonucleotide probe is dissolved in 3 × SSC solution with 15 μM of concentration, and oligonucleotides is sprayed on the slide of aldehyde radical with PixySys5500 chip preparing instrument, and point spacing is 0.5mm.After point sample, left at room temperature over night.
The application method of alcohol metabolism relative enzyme gene polymorphic test chip are as follows:
1) slide for being loaded with oligonucleotide probe is respectively washed twice using preceding 0.2%SDS and clear water, it is air-dried rear 1%NaBH4 solution reduction 10min, 0.2%SDS is washed once, and washing is primary, with for use after being air-dried, complete the covalent immobilization of probe in surface of glass slide.
2) contain 50ng DNA, 4 pairs of primers (table 2), 10mM Tris-HClpH8.3,50mM KCl, 1.5mM MgCl in 20ul PCR reaction system2, 200uM dNTP and 1.5 unit Taq enzymes；Wherein primer content is 20ng Cyp-3 fluorescent dye primer, 2ng general primer.PCR cycle condition: 95 DEG C of denaturation in 5 minutes；94 DEG C of denaturation of each 45 seconds of 35 circulations, 57.5 DEG C of annealing, 72 DEG C of extensions；It is finally 72 DEG C of extensions in 5 minutes.
3) after 2ulPCR product is mixed with 10ul hybridization buffer, hybridize 1 hour with the oligonucleotide probe slide prepared at 42 DEG C, then respectively with 1 × SSC, 0.2%SDS, 0.2 × SSC, 0.1 × SSC cleaning, it is finally detected with laser co-focusing Fluorescence Scanner ScanArray 3000, is scanned 3 times under 85% laser intensity.Positive control probe composition is analyzed, judges the differentiation of the gene pleiomorphism of alcohol metabolism relevant enzyme.Alcohol metabolism relative enzyme gene polymorphic test chip uses example: to 165 wine-heads, wherein 43 without liver damage, it is alcoholic liver disease 122, the age 25~70 years old, 44.0 years old average.It is Normal group 65, the age 26~68 years old, 45.9 years old average.All research objects are all from Zhejiang Province Epidemiology of alcoholic liver diseases survey group.Diagnostic criteria excludes virus B hepatitis surface antigen and viral hepatitis type C antibody positive referring to " diagnosis basis of alcoholic liver disease and healing, improvement standard [3] ", and the person of not being true to type does needle biopsy of liver.All objects extract 3ml peripheral blood, routinely extract DNA and are detected with the said chip above method.As a result are as follows: 1) ADH2 gene polynorphisms: healthy control group, wine-head's group, the ADH2*1 gene frequency without liver damage group and alcoholic liver disease group are respectively 37.69%, 55.76%, 46.51%, 59.02%；ADH2*2 gene frequency is respectively 62.31%, 44.24%, 53.49%, 40.98%；ADH2*3 allele is not found.The ADH2*1 frequency of wine-head and patients with alcoholic liver disease is apparently higher than healthy control group, and patients with alcoholic liver disease is higher than the wine-head without liver damage；2) ADH3 gene pleiomorphism: for the gene frequency of the ADH3 gene of wine-head and alcoholic liver disease compared with healthy control group, the ADH3*2 frequency of the wine-head of no liver damage is higher than normal healthy controls.3) ALDH2 gene pleiomorphism: the ALDH2*2 gene frequency of wine-head and patients with alcoholic liver disease is lower than healthy control group, and patients with alcoholic liver disease ALDH2*2 gene frequency is substantially less than the wine-head [4] without liver damage.
Claims (9)
1, a kind of alcohol metabolism relative enzyme gene polymorphic test chip, it is characterised in that: following probe is equipped on carrier:
ADH3:5 '-AAG GTA AAA CAT TTG TTAT
5’-AAG GTA AAA TAT TTG TTAT
5’-AAG GTA AAA AAT TTG TTAT
5’-AAG GTA AAA GAT TTG TTAT
ADH2 (allele 1 and allele 2): 5 '-AAT CTG TCG CAC AGA TG
` 5’-AAG GTA AAA CAT TTG TTAT
5’-AAT CTG TCC CAC AGA TG
5’-AAT CTG TCT CAC AGA TG
ADH2 (allele 1 and allele 3): 5 '-GCA GTA TCT GTA CCG TC
5’-GCA GTA TCC GTA CCG TC
5’-GCA GTA TCA GTA CCG TC
5’-GCA GTA TCG GTA CCG TC
ALDH2:5 '-CAT ACA CTG AAG TGA AA
5’-CAT ACA CTA AAG TGA AA
5’-CAT ACA CTT AAG TGA AA
5’-CAT ACA CTC AAG TGA AA
2, a kind of alcohol metabolism relative enzyme gene polymorphic test chip according to claim 1, it is characterised in that: described carrier is slide.
3, a kind of preparation method of alcohol metabolism relative enzyme gene polymorphic test chip, it is characterised in that: method and step are as follows:
1) processing of chip carrier: wave carrier piece chromic acid lotion soaked overnight, washing, in 24~26% ammonium hydroxide overnight, washing, slide immerses in 95% ethanol solution of aminopropyl trimethoxysilane, adjusts PH to 4~4.5, the cleaning of 95% EtOH Sonicate with glacial acetic acid, 150~160 DEG C dry 3~5 hours, and 9~11% glutaraldehydes are processed into aldehyde radical；
2) synthesis of primer and probe: a set of probe is devised for Alcohol-metabolizing enzymes related gene ADH2, ADH3 and ALDH2 gene; 4 pairs of primers have been synthesized for the design of Alcohol-metabolizing enzymes related gene ADH2, ADH3 and ALDH2 gene; respectively there is a Cyp-3 signaling molecule label in each pair of primer; with 75~85 DEG C of concentrated ammonia liquor deprotections after synthesis; cutting 13~17 hours; OPC column purification, it is ultraviolet it is quantitative after be dried in vacuo concentration, -20~-80 DEG C save backup；
3) genetic chip preparation and post-processing: oligonucleotide probe is dissolved in 3 × SSC solution with 15 μM of concentration, and oligonucleotides is sprayed on the slide of aldehyde radical with PixySys5500 chip preparing instrument, and point spacing is 0.5mm.After point sample, left at room temperature over night immobilization.
4, the preparation method of a kind of alcohol metabolism relative enzyme gene polymorphic test chip according to claim 3, it is characterized by: immobilised probe is oligonucleotide probe on described slide, its sequence is designed according to the gene expression characteristics of Alcohol-metabolizing enzymes related gene ADH2, ADH3 and ALDH2, for its length range in 15-20 base, Tm value is 40~43 DEG C.
5, the preparation method of a kind of alcohol metabolism relative enzyme gene polymorphic test chip according to claim 3, it is characterised in that: described probe is:
ADH3:5 '-AAG GTA AAA CAT TTG TTAT
5’-AAG GTA AAA TAT TTG TTAT
5’-AAG GTA AAA AAT TTG TTAT
5’-AAG GTA AAA GAT TTG TTAT
ADH2 (allele 1 and allele 2): 5 '-AAT CTG TCG CAC AGA TG
5’-AAG GTA AAA CAT TTG TTAT
5’-AAT CTG TCC CAC AGA TG
5’-AAT CTG TCT CAC AGA TG
ADH2 (allele 1 and allele 3): 5 '-GCA GTA TCT GTA CCG TC
5’-GCA GTA TCC GTA CCG TC
5’-GCA GTA TCA GTA CCG TC
5’-GCA GTA TCG GTA CCG TC
ALDH2:5 '-CAT ACA CTG AAG TGA AA
5’-CAT ACA CTA AAG TGA AA
5’-CAT ACA CTT AAG TGA AA
5’-CAT ACA CTC AAG TGA AA
6, the preparation method of a kind of alcohol metabolism relative enzyme gene polymorphic test chip according to claim 3, it is characterized by: described primer is that root one is designed according to the gene expression characteristics of Alcohol-metabolizing enzymes related gene ADH2, ADH3 and ALDH2, primer sequence length is respectively used to the amplification of said gene between 20-24 base.
7, a kind of preparation method of alcohol metabolism relative enzyme gene polymorphic test chip according to claim 3, it is characterised in that: described primer are as follows:
Gene C yp-3 fluorescent dye primer primer
ADH3 5’-CTT TAA GAG TAA AGA ATC TGT CC-3’ 5’-ACC TCT TTC CAG
AGC GAA GCAG-3’
ADH2 5’-GAA GGG GGG TCA CCA GGT TGC-3’ 5’-AAT CTT TTC TGA
ATC TGA ACAG-3’
(allele 1 and allele 2)
ADH2 5’-TTG ATA ACA TCT CTG AAG AGC TGA-3’ 5’-TGG ACT CTC ACA
ACA AGC ATGT-3’
(allele 1 and allele 3)
ALDH2 5’-CAG GTC CCA CAC TCA CAG TTT-3’ 5’-CAC CCT TTG GTG
GCT ACA AG-3’
8, the preparation method of a kind of alcohol metabolism relative enzyme gene polymorphic test chip according to claim 3, it is characterised in that: described signaling molecule label is fluorescent molecule.
9, a kind of purposes of alcohol metabolism relative enzyme gene polymorphic test chip, it is characterised in that polymorphic detection and parting for patients with alcoholic liver disease Alcohol-metabolizing enzymes related gene ADH2, ADH3 and ALDH2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410017946 CN1268769C (en) | 2004-04-21 | 2004-04-21 | Polymorphism detection chip for gene of enzyme relevant to ethanol metabolism, preparation method of usage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410017946 CN1268769C (en) | 2004-04-21 | 2004-04-21 | Polymorphism detection chip for gene of enzyme relevant to ethanol metabolism, preparation method of usage |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1563421A true CN1563421A (en) | 2005-01-12 |
| CN1268769C CN1268769C (en) | 2006-08-09 |
Family
ID=34479252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410017946 Expired - Fee Related CN1268769C (en) | 2004-04-21 | 2004-04-21 | Polymorphism detection chip for gene of enzyme relevant to ethanol metabolism, preparation method of usage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1268769C (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007039550A3 (en) * | 2005-09-29 | 2007-08-09 | Proyecto Biomedicina Cima Sl | Molecular markers of hepatocellular carcinoma and their applications |
| CN102146438A (en) * | 2010-12-22 | 2011-08-10 | 协和干细胞基因工程有限公司 | Kit for detecting alcoholic liver disease susceptibility |
| CN102549171A (en) * | 2009-10-07 | 2012-07-04 | 学校法人武库川学院 | Genotype Judgment Method |
| CN103361432A (en) * | 2013-07-26 | 2013-10-23 | 天津市秀鹏生物技术开发有限公司 | Primer group and kit for detecting genetic typing of human aldehyde dehydrogenase 2 (ALDH2) |
| CN103540675A (en) * | 2013-10-31 | 2014-01-29 | 上海百傲科技股份有限公司 | Specific primer pair and probe for detecting ALDH2 (alcohol dehydrogenase 2) gene chip |
| CN103834733A (en) * | 2014-02-27 | 2014-06-04 | 厦门大学附属中山医院 | Kit and method for determining mutation sites of genes of acetaldehyde dehydrogenase 2 and methylene tetrahydrofolic acid reductase by virtue of single tube at the same time |
| CN104156632A (en) * | 2014-07-21 | 2014-11-19 | 金华市中心医院 | Method for intelligently designing drug metabolic enzyme detecting gene chip probes |
| CN113774115A (en) * | 2021-08-04 | 2021-12-10 | 上海百傲科技股份有限公司 | Method, kit, primer pair, probe, gene chip and application for detecting ALDH2 gene |
-
2004
- 2004-04-21 CN CN 200410017946 patent/CN1268769C/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007039550A3 (en) * | 2005-09-29 | 2007-08-09 | Proyecto Biomedicina Cima Sl | Molecular markers of hepatocellular carcinoma and their applications |
| CN102549171A (en) * | 2009-10-07 | 2012-07-04 | 学校法人武库川学院 | Genotype Judgment Method |
| CN102146438A (en) * | 2010-12-22 | 2011-08-10 | 协和干细胞基因工程有限公司 | Kit for detecting alcoholic liver disease susceptibility |
| CN103361432A (en) * | 2013-07-26 | 2013-10-23 | 天津市秀鹏生物技术开发有限公司 | Primer group and kit for detecting genetic typing of human aldehyde dehydrogenase 2 (ALDH2) |
| CN103540675A (en) * | 2013-10-31 | 2014-01-29 | 上海百傲科技股份有限公司 | Specific primer pair and probe for detecting ALDH2 (alcohol dehydrogenase 2) gene chip |
| CN103834733A (en) * | 2014-02-27 | 2014-06-04 | 厦门大学附属中山医院 | Kit and method for determining mutation sites of genes of acetaldehyde dehydrogenase 2 and methylene tetrahydrofolic acid reductase by virtue of single tube at the same time |
| CN104156632A (en) * | 2014-07-21 | 2014-11-19 | 金华市中心医院 | Method for intelligently designing drug metabolic enzyme detecting gene chip probes |
| CN113774115A (en) * | 2021-08-04 | 2021-12-10 | 上海百傲科技股份有限公司 | Method, kit, primer pair, probe, gene chip and application for detecting ALDH2 gene |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1268769C (en) | 2006-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101072900B1 (en) | Method for selective labeling and detection of target nucleic acids using immobilized peptide nucleic acid probes | |
| US5834181A (en) | High throughput screening method for sequences or genetic alterations in nucleic acids | |
| JP3693352B2 (en) | Methods for detecting genetic polymorphisms and monitoring allelic expression using probe arrays | |
| CN101619352B (en) | Double-probe gene mutation detecting method based on allele special amplification as well as special chip and kit thereof | |
| CN101034061A (en) | Method for detecting mononucleotide polymorphism with biochip | |
| JPH10506267A (en) | High-throughput screening for nucleic acid sequence or genetic changes | |
| KR20010012175A (en) | Two-step hybridization and capture of a polynucleotide | |
| CA2369878A1 (en) | Comparative fluorescence hybridization to oligonucleotide microarrays | |
| AU2002348612A1 (en) | Hybridization portion control oligonucleotide and it's uses | |
| US20090148849A1 (en) | One-step target detection assay | |
| EP1645640A2 (en) | Methods for amplifying and analyzing nucleic acids | |
| CN1195070C (en) | Detection type gene chip for detecting various infectious desease and use thereof | |
| CN1268769C (en) | Polymorphism detection chip for gene of enzyme relevant to ethanol metabolism, preparation method of usage | |
| EP1612282B1 (en) | Probe set and substrate for detecting nucleic acid | |
| Bang‐Ce et al. | Rapid detection of common Chinese glucose‐6‐phosphate dehydrogenase (G6PD) mutations by microarray‐based assay | |
| KR100818276B1 (en) | Primer sets, probe sets, methods and kits for predicting alcohol degradability and hangover occurrence | |
| CN110819708A (en) | Method for detecting ALDH2 gene polymorphism by fluorescent quantitative PCR | |
| CN114369597B (en) | Universal probe detection chip and application thereof | |
| JP2000513202A (en) | Large-scale screening of nucleic acid sequencing or genetic replacement | |
| CN1814794A (en) | Leptin and leptin receptor gene polymorphism detecting chip, and its preparing method and use | |
| CN1442487A (en) | Kynurenine hydrolase polymorphism and its diagnostic use | |
| CN1277933C (en) | Method and composite for identifying nucleic acid molecule by nucleic acid enzymolysis activity and hybrid technology | |
| CN101240344A (en) | Plasmodium falciparum drug resistance related gene polymorphism detection chip and its application | |
| Zou et al. | DNA microarrays: applications, future trends, and the need for standardization | |
| KR20090107374A (en) | PENA probe, kit and method for detecting genotype of cytochrome P450 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060809 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |